Literature DB >> 22040178

Biophysical modeling to simulate the response to multisite left ventricular stimulation using a quadripolar pacing lead.

Steven A Niederer1, A K Shetty, G Plank, J Bostock, R Razavi, N P Smith, C A Rinaldi.   

Abstract

BACKGROUND: Response to cardiac resynchronization therapy (CRT) is reduced in patients with posterolateral scar. Multipolar pacing leads offer the ability to select desirable pacing sites and/or stimulate from multiple pacing sites concurrently using a single lead position. Despite this potential, the clinical evaluation and identification of metrics for optimization of multisite CRT (MCRT) has not been performed.
METHODS: The efficacy of MCRT via a quadripolar lead with two left ventricular (LV) pacing sites in conjunction with right ventricular pacing was compared with single-site LV pacing using a coupled electromechanical biophysical model of the human heart with no, mild, or severe scar in the LV posterolateral wall. RESULT: The maximum dP/dt(max) improvement from baseline was 21%, 23%, and 21% for standard CRT versus 22%, 24%, and 25% for MCRT for no, mild, and severe scar, respectively. In the presence of severe scar, there was an incremental benefit of multisite versus standard CRT (25% vs 21%, 19% relative improvement in response). Minimizing total activation time (analogous to QRS duration) or minimizing the activation time of short-axis slices of the heart did not correlate with CRT response. The peak electrical activation wave area in the LV corresponded with CRT response with an R(2) value between 0.42 and 0.75.
CONCLUSION: Biophysical modeling predicts that in the presence of posterolateral scar MCRT offers an improved response over conventional CRT. Maximizing the activation wave area in the LV had the most consistent correlation with CRT response, independent of pacing protocol, scar size, or lead location. ©2011, The Authors. Journal compilation ©2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22040178      PMCID: PMC5378306          DOI: 10.1111/j.1540-8159.2011.03243.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  35 in total

1.  Non-contact left ventricular endocardial mapping in cardiac resynchronisation therapy.

Authors:  P D Lambiase; A Rinaldi; J Hauck; M Mobb; D Elliott; S Mohammad; J S Gill; C A Bucknall
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

2.  Left ventricular pacing with a new quadripolar transvenous lead for CRT: early results of a prospective comparison with conventional implant outcomes.

Authors:  Giovanni B Forleo; Domenico G Della Rocca; Lida P Papavasileiou; Arianna Di Molfetta; Luca Santini; Francesco Romeo
Journal:  Heart Rhythm       Date:  2010-09-29       Impact factor: 6.343

3.  Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy.

Authors:  Claudia Ypenburg; Rutger J van Bommel; Victoria Delgado; Sjoerd A Mollema; Gabe B Bleeker; Eric Boersma; Martin J Schalij; Jeroen J Bax
Journal:  J Am Coll Cardiol       Date:  2008-10-21       Impact factor: 24.094

4.  A note on conduction velocity.

Authors:  A L HODGKIN
Journal:  J Physiol       Date:  1954-07-28       Impact factor: 5.182

5.  Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial.

Authors:  Jagmeet P Singh; Helmut U Klein; David T Huang; Sven Reek; Malte Kuniss; Aurelio Quesada; Alon Barsheshet; David Cannom; Ilan Goldenberg; Scott McNitt; James P Daubert; Wojciech Zareba; Arthur J Moss
Journal:  Circulation       Date:  2011-03-07       Impact factor: 29.690

6.  Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony.

Authors:  Maria Vittoria Pitzalis; Massimo Iacoviello; Roberta Romito; Francesco Massari; Brian Rizzon; Giovanni Luzzi; Pietro Guida; Andrea Andriani; Filippo Mastropasqua; Paolo Rizzon
Journal:  J Am Coll Cardiol       Date:  2002-11-06       Impact factor: 24.094

7.  A comparison of ventricular function during high right ventricular septal and apical pacing after his-bundle ablation for refractory atrial fibrillation.

Authors:  F Mera; D B DeLurgio; R E Patterson; J D Merlino; M E Wade; A R León
Journal:  Pacing Clin Electrophysiol       Date:  1999-08       Impact factor: 1.976

8.  Electrocardiographic predictive factors of long-term clinical improvement with multisite biventricular pacing in advanced heart failure.

Authors:  C Alonso; C Leclercq; F Victor; H Mansour; C de Place; D Pavin; F Carré; P Mabo; J C Daubert
Journal:  Am J Cardiol       Date:  1999-12-15       Impact factor: 2.778

9.  Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy.

Authors:  Cheuk-Man Yu; Wing-Hong Fung; Hong Lin; Qing Zhang; John E Sanderson; Chu-Pak Lau
Journal:  Am J Cardiol       Date:  2003-03-15       Impact factor: 2.778

10.  Use of a quadripolar left ventricular lead to achieve successful implantation in patients with previous failed attempts at cardiac resynchronization therapy.

Authors:  Anoop K Shetty; Simon G Duckett; Julian Bostock; Eric Rosenthal; C Aldo Rinaldi
Journal:  Europace       Date:  2011-02-22       Impact factor: 5.214

View more
  32 in total

Review 1.  Updates in Cardiac Resynchronization Therapy for Chronic Heart Failure: Review of Multisite Pacing.

Authors:  Antonios P Antoniadis; Ben Sieniewicz; Justin Gould; Bradley Porter; Jessica Webb; Simon Claridge; Jonathan M Behar; Christopher Aldo Rinaldi
Journal:  Curr Heart Fail Rep       Date:  2017-10

Review 2.  At the heart of computational modelling.

Authors:  S A Niederer; N P Smith
Journal:  J Physiol       Date:  2012-01-23       Impact factor: 5.182

3.  Limitations of chronic delivery of multi-vein left ventricular stimulation for cardiac resynchronization therapy.

Authors:  Jonathan M Behar; Julian Bostock; Matthew Ginks; Tom Jackson; Manav Sohal; Simon Claridge; Reza Razavi; Christopher Aldo Rinaldi
Journal:  J Interv Card Electrophysiol       Date:  2015-01-28       Impact factor: 1.900

Review 4.  Current developments in cardiac rhythm management devices.

Authors:  Philipp Halbfass; Kai Sonne; Karin Nentwich; Elena Ene; Thomas Deneke
Journal:  Clin Res Cardiol       Date:  2018-06-27       Impact factor: 5.460

Review 5.  Interpreting genetic effects through models of cardiac electromechanics.

Authors:  S A Niederer; S Land; S W Omholt; N P Smith
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-10-05       Impact factor: 4.733

Review 6.  Multisite Pacing for Cardiac Resynchronization Therapy: Promise and Pitfalls.

Authors:  Antonios P Antoniadis; Jonathan M Behar; Simon Claridge; Tom Jackson; Manav Sohal; Christopher Aldo Rinaldi
Journal:  Curr Cardiol Rep       Date:  2016-07       Impact factor: 2.931

Review 7.  A computational approach to understanding the cardiac electromechanical activation sequence in the normal and failing heart, with translation to the clinical practice of CRT.

Authors:  Jason Constantino; Yuxuan Hu; Natalia A Trayanova
Journal:  Prog Biophys Mol Biol       Date:  2012-08-01       Impact factor: 3.667

Review 8.  Using physiologically based models for clinical translation: predictive modelling, data interpretation or something in-between?

Authors:  Steven A Niederer; Nic P Smith
Journal:  J Physiol       Date:  2016-07-03       Impact factor: 5.182

Review 9.  Clinical Applications of Patient-Specific Models: The Case for a Simple Approach.

Authors:  Jeffrey W Holmes; Joost Lumens
Journal:  J Cardiovasc Transl Res       Date:  2018-02-16       Impact factor: 4.132

10.  Acute changes in electromechanical parameters during different pacing configurations using a quadripolar left ventricular lead.

Authors:  Cinzia Valzania; Maria J Eriksson; Mauro Biffi; Giuseppe Boriani; Fredrik Gadler
Journal:  J Interv Card Electrophysiol       Date:  2013-07-03       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.